Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital

Patient Education and Counseling

Volumn 81, Issue 2, 2010, Pages 161-168

  Jansà, Margarida ^a   Hernández, Carme ^a   Vidal, Mercè ^a   Nuñez, Montse ^a   Bertran, M Jesús ^a   Sanz, Sergi ^a   Castell, Conxa ^b   Sanz, Ginés ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b Public Health Division   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Adherence; Chronic conditions; Chronic treatment complexity; Fixed dose pill combination; Patient education

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER PATIENT; CHRONIC DISEASE; CHRONIC PATIENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET; DRUG USE; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PILL; PRIORITY JOURNAL; RANDOM SAMPLE; SELF CARE; SELF MONITORING; SMOKING; STRUCTURED INTERVIEW; TERTIARY HEALTH CARE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, TEACHING; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; POLYPHARMACY; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF ADMINISTRATION; SOCIOECONOMIC FACTORS; SPAIN; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77957272010     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2009.12.012     Document Type: Article

References (48)

1. Epping-Jordan J.E., Pruitt S.D., Bengoa R., Wagner E.H. Improving the quality of health care for chronic conditions. Qual Saf Health Care 2004, 13:299-305.
2. Broemeling A.M., Watson D.E., Prebtani F. Population patterns of chronic health conditions, co-morbidity and healthcare use in Canada: implications for policy and practice. Health Q 2008, 11:70-76.
3. Hernández C., Jansà M., Nuñez M., Vidal M., Garcia-Aymerich J., Roca J. The burden of chronic disorders on hospital admissions prompts the need for new modalities of care. A cross-sectional analysis in a tertiary hospital. QJM-MON J ASSOC PHYS 2009, 102:193-202. 10.1093/qjmed/hcn172.
4. Madden J.M., Graves A.J., Zhang F., Adams A.S., Briesacher B.A., Ross-Degnan D., et al. Cost-related medication non adherence and spending on basic needs following implementation of Medicare Part D. J Amer Med Assoc 2008, 299:1922-1928.
5. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, 16:CD000011.
6. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-209.
7. Simpson S.H., Eurich D.T., Majumdar S.R., Padwal R.S., Tsuyuki R.T., Varney J., et al. A meta-analysis of the association between adherence to drug therapy and mortality. Brit Med J 2006, 333:15-18.
8. van Dulmen S., Sluijs E., van Dijk L., de Ridder D., Heerdink R., Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007, 7:55. [review].
9. Bosworth H.B., Oddone E.Z., Weinberger M. Patient treatment adherence. Concepts, interventions and measurements 2006, Lawrence Erlbaum Associates Publishers, New Jersey, London. H.B. Bosworth, E.Z. Oddone, M. Weinberger (Eds.).
10. Clifford S., Barber N., Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res 2008, 64:41-46.
11. Lihara N., Kurosaki Y., Miyoshi C., Takabatake K., Morita S., Hori K. Comparison of individual perceptions of medication costs and benefits between intentional and unintentional medication non-adherence among Japanese patients. Patient Educ Couns 2008, 70:292-299.
12. Lowry K.P., Dudley T.K., Oddone E.Z., Bosworth H.B. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005, 39:1198-1203.
13. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497. [review].
14. van Dulmen S., Sluijs E., van Dijk L., de Ridder D., Heerdink R., Bensing J. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res 2008, 27:47.
15. Ho P.M., Bryson C.L., Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-3033.
16. World Health Organization. Adherence to long-term therapies. Evidence for action. ; 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html.
17. Vogeli C., Shields A.E., Lee T.A., Gibson T.B., Marder W.D., Weiss K.B., et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007, 22(Suppl. 3):391-395. [review].
18. Williams A., Manias E., Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 2008, 63:132-143.
19. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
20. Generalitat de Catalunya. Departament de Sanitat i Seguretat social. Enquesta de salut de Catalunya (ESCA 2002). http://www.gencat.cat/salut/depsalut/html/ca/plasalut/doc5365.html.
21. Vidal M., Jansà M., Anguita C., Torres M., Jiménez M., Esmatjes E., et al. Impact of a special therapeutic education programme in patients transferred from a paediatric to an adult diabetes unit. Eur Diabetes Nurs 2004, 1:23-27.
22. Generalitat de Catalunya. CatSalut. The Catalan Health Care Model. ; 2002. http://www10.gencat.net/catsalut/eng/coneix_models.htm.
23. Codina C.J., Sardà P.U., Salvador E.L., Monterde J.J., Ribas J.S. Database program for creating individualized patient drug information and medication schedules. Am J Hosp Pharm 1992, 49:131-132.
24. Activitat assistencial de la xarxa sanitaria de Catalunya. Conjunt minim basic de dades (CMBD). Generalitat de Catalunya. " CatSalut" http://www10.gencat.net/catsalut/archivos/publicacions/estad_sanitaries/cmbd_2000/cmbd_ing.htm.
25. Charlson M.E., Pompei P., Ales K.L., Mackenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
26. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel index. Maryland State Med J 1965, 14:61-65.
27. Smilkstein G. The Family APGAR: a proposal for a family function test and its use by physicians. J Fam Practice 1978, 6:1231-1239.
28. George C.F., Peveler R.C., Heiliger S., Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Brit J Clin Pharmacol 2000, 50:166-171.
29. Elm J.J., Kamp C., Tilley B.C., Guimaraes P., Fraser D., Deppen P., et al. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Movement Disord 2007, 22:822-827.
30. Nelson R.M., Reid C.M., Ryan P., Willson K., Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Australia 2006, 185:487-489.
31. Ministerio de Trabajo e Inmigración. Inmigración y mercado de trabajo. ; 2008. http://extranjeros.mtin.es/es/ObservatorioPermanenteIntegracion/Publicaciones/archivos/Inmigracixn_y_Mercado_de_trabajo._Informe_2008.pdf.
32. Martin M.T., Codina C., Tuset M., Carne X., Nogue S., Ribas J. Drug related problems as a cause of hospital admission. Med Clin-Barcelona 2002, 23:205-210.
33. Kravitz R.L., Melnikow J. Medical adherence research: time for a change in direction?. Med Care 2004, 42:197-199.
34. Barlow J., Wright C., Sheasby J., Turner A., Hainsworth J. Self management approaches for people with chronic conditions: a review. Patient Educ Couns 2002, 48:177-187.
35. Newman S., Steed L., Mulligan K. Self-management interventions for chronic illness. Review article. Lancet 2004, 364:523-537.
36. Golay A., Lagger G., Chambouleyron M., Carrard I., Lasserre-Moutet A. Therapeutic education of diabetic patients. Diabetes Metab Res Rev 2008, 24:192-196.
37. Powers B.J., Olsen M.K., Oddone E.Z., Bosworth H.B. The effect of a hypertension self-management intervention on diabetes and cholesterol control. Am J Med 2009, 122:639-646.
38. Kripalani S., Yao X., Haynes R.B. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007, 167:540-550. [review].
39. Conget I., Jansà M., Vidal M., Manzanares J.M., Vidal J., Gomis R. Effects of an individual intensive educational control program for insulin-dependent diabetic subjects with poor metabolic control. Diabetes Res Clin Pr 1995, 27:189-192.
40. Jansa M., Vidal M., Viaplana J., Conget I., Levy I., Gomis R., et al. Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. A random prospective pilot study. Diabetes Res Clin Pr 2006, 74:26-32.
41. Figuerola D., Recasens A., Castell C., Lloveras G. Care for the diabetic patient in Catalonia. A study of a population sample. Med Clin-Barcelona 1992, 99:90-95. [Spanish].
42. Wise J. Polypill holds promise for people with chronic disease. B World Health Organ 2005, 83:885-887. http://www.who.int/bulletin/volumes/83/12/news11205/en/index.html.
43. Bangalore S., Kamalakkannan G., Parkar S., Messerli F.H. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007, 120:713-719.
44. Wald N.J., Law M.R. A strategy to reduce cardiovascular disease by more than 80%. Brit Med J 2003, 326:1419.
45. Fuster V., Sanz G. A polypill for secondary prevention: time to move from intellectual debate to action. Nat Clin Pract Cardiovasc Med 2007, 4:173.
46. Costantino G., Ceriani E., Rusconi A.M., Montano N. Prevention of cardiovascular disease with a polypill. Lancet 2007, 369:185-186.
47. Rosenthal T., Gavras I. Fixed-drug combinations as first-line treatment for hypertension. Prog Cardiovasc Dis 2006, 48:416-425.
48. van Dijk L., Heerdink E.R., Somai D., van Dulmen S., Sluijs E.M., de Ridder D.T., et al. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res 2007, 10:7-51.